The FDA approved re-administration of iDose TR for patients with healthy corneas, enhancing treatment flexibility for ...
Opus Genetics is conducting a trial for OPGx-MERTK gene therapy in Abu Dhabi, targeting MERTK-related retinitis pigmentosa ...
The study highlights the importance of shear-thinning behavior in artificial tears, crucial for mimicking natural tear properties and ensuring ocular surface protection. Hyaluronic acid's ...
Myra Vision has treated the first patient in its ADAPT clinical study evaluating the Calibreye TGT Surgical System in ...
Retinal imaging during ROP screening can predict bronchopulmonary dysplasia and pulmonary hypertension in preterm infants, ...
The US Food and Drug Administration (FDA) has cleared Novaliq’s Investigational New Drug (IND) application for NOV05, enabling the initiation of the EYETAC phase II clinical trial ( NCT07285070) in ...
For patients for whom surgery is indicated but who are opposed to undergoing glaucoma surgery, he may suggest a different ...
CBT-004 is a novel, preservative-free ophthalmic solution targeting VEGF and PDGF receptors to treat vascularized pinguecula. Phase 2 trial results showed significant improvements in conjunctival ...
From artificial intelligence and IOL innovation to biosimilars, geographic atrophy, and postoperative eye protection, Joshua ...
FDA authorizes compassionate use of urcosimod for neuropathic corneal pain, a condition that causes severe pain and ...
Prostaglandin analogues, such as latanoprost and bimatoprost, are the go-to therapies for glaucoma therapy. They continue to ...
Glaucoma specialists are marking their calendars for January 31, 2026—when the 2nd International Glaucoma Symposium will take ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results